Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
02/2000
02/10/2000WO2000006728A2 Phosphorylation effectors
02/10/2000WO2000006727A2 Human epidermal proteins hepi-1 to hepi-6
02/10/2000WO2000006726A2 Delta-related polypeptides
02/10/2000WO2000006725A1 Method for diagnosing hereditary diseases by using semaphorin w gene
02/10/2000WO2000006724A1 Remedies for neuropathy containing as the active ingredient galectin-1 or its derivatives
02/10/2000WO2000006723A1 Tumor associated antigen peptides and use of same as anti-tumor vaccines
02/10/2000WO2000006722A1 Eukaryotic cell-based gene interaction cloning
02/10/2000WO2000006721A1 Serological diagnosis of protostrongylidae infections and identification of unique antigens
02/10/2000WO2000006720A1 A novel regulatory molecule and genetic sequences encoding same
02/10/2000WO2000006719A1 Nucleic acids encoding proteins involved in sensory transduction
02/10/2000WO2000006718A2 Expression of functional eukaryotic proteins
02/10/2000WO2000006717A2 Improved transformation efficiency in phage display through modification of a coat protein
02/10/2000WO2000006716A1 Growth differentiation factor-11
02/10/2000WO2000006715A1 Automatic eukaryotic artificial chromosome vector
02/10/2000WO2000006713A2 Methods for recombinant protein production in mammalian cells comprising co-expression with fetuin
02/10/2000WO2000006712A2 Protein tyrosine phosphatase-1b (ptp-1b) deficient mice and uses thereof
02/10/2000WO2000006709A1 Human protein kinase h2lau20
02/10/2000WO2000006708A1 Novel polypeptide
02/10/2000WO2000006706A2 Map kinase phosphatase mutant
02/10/2000WO2000006705A2 Genetically modified cd34-negative adherently growing stem cells and their use in gene therapy
02/10/2000WO2000006702A1 Cancer cells from body fluids containing cells, isolation thereof and agents containing the same
02/10/2000WO2000006698A1 98 human secreted proteins
02/10/2000WO2000006696A2 Method for the modulation of function of transcription factors
02/10/2000WO2000006694A2 Compound and method for the prevention and/or the treatment of allergy
02/10/2000WO2000006605A2 Heterominibodies
02/10/2000WO2000006601A1 Isoforms of human calcium sensing receptor
02/10/2000WO2000006600A1 Human mink gene mutations associated with arrhythmia
02/10/2000WO2000006598A1 Endogenous retrovirus tumor associated nucleic acids and antigens
02/10/2000WO2000006597A2 Endogenous constitutively activated g protein-coupled orphan receptors
02/10/2000WO2000006596A2 Interferon alpha hybrids
02/10/2000WO2000006595A1 Hla-a2 restraint tumor antigen peptide originating in sart-1
02/10/2000WO2000006593A1 Nucleic acids encoding a g-protein coupled receptor involved in sensory transduction
02/10/2000WO2000006592A1 Nucleic acids encoding a g-protein coupled receptor involved in sensory transduction
02/10/2000WO2000006589A1 Prostate derived ets factor
02/10/2000WO2000006588A1 STEREOISOMERS OF CpG OLIGONUCLEOTIDES AND RELATED METHODS
02/10/2000WO2000006206A1 Compositions and methods for the treatment and diagnosis of cardiovascular disease
02/10/2000WO2000006205A1 Regulated expression of recombinant proteins using rna viruses
02/10/2000WO2000006204A2 Genetically engineered cells and tissues
02/10/2000WO2000006199A1 Kvlqt1 - a long qt syndrome gene
02/10/2000WO2000006195A1 Targeting pharmaceutical agents to injured tissues
02/10/2000WO2000006183A1 C7F2-A NOVEL POTASSIUM CHANNEL β-SUBUNIT
02/10/2000WO2000006120A1 Lipid emulsion and solid lipid nanoparticle as a gene or drug carrier
02/10/2000WO2000006032A1 Ultrasonic enhancement of drug injection
02/10/2000WO2000000598A3 Plant dwarfing
02/10/2000WO2000000510A8 Growth factor modulators
02/10/2000WO1999067356A3 Propionibacterium vector
02/10/2000WO1999065927A3 Method for producing polynucleotides with desired properties
02/10/2000WO1999064613B1 D-ribulose-5-phosphate-3-epimerase nematode response gene
02/10/2000WO1999064603A3 ENHANCEMENT OF B CELL ACTIVATION AND IMMUNOGLOBULIN SECRETION BY CO-STIMULATION OF RECEPTORS FOR ANTIGEN AND EBV Gp350/220
02/10/2000WO1999062526A3 Use of genetically engineered antibodies to cd38 to treat multiple myeloma
02/10/2000WO1999061600A3 A method of modulating the efficiency of translation termination and degradation of aberrant mrna involving a surveillance complex comprising human upf1p, eucaryotic release factor 1 and eucaryotic release factor 3
02/10/2000WO1999060024A9 Methods for amyloid removal using anti-amyloid antibodies
02/10/2000WO1999058678A3 Antibodies to dendritic cells and human dendritic cell populations and uses thereof
02/10/2000WO1999058674A3 Method of inhibiting osteoclast activity
02/10/2000WO1999054479A9 INHIBITION OF ALKYL HYDROPEROXIDE REDUCTASE, SUBUNIT C (AhpC) TO IMPART SUSCEPTIBILITY TO ANTIMICROBIAL REACTIVE NITROGEN INTERMEDIATES
02/10/2000WO1999053073A3 Interconversion of plant fatty acid desaturases and hydroxylases
02/10/2000WO1999053038A3 Mutant proteins having lower allergenic response in humans and methods for constructing, identifying and producing such proteins
02/10/2000WO1999049045A3 Recombinant major allergen of the pollen of artemisia vulgaris (mugwort)
02/10/2000WO1999049039A3 GFRα3 AND ITS USES
02/10/2000WO1999049038A3 Human calcium-binding proteins
02/10/2000WO1999045126A3 Enhanced prodrug activation
02/10/2000WO1999045116A3 Human homolog of a nuclear migration gene and its use
02/10/2000WO1999041376A3 Retinoblastoma protein complexes and retinoblastoma interacting proteins
02/10/2000WO1999024580A3 Essential fungal genes and their use
02/10/2000DE19835611A1 Neuartige Phospholipide mit synthetischen, ungesättigten Alkyl- und Acylketten Novel synthetic phospholipids with unsaturated alkyl and acyl chains
02/10/2000DE19835219A1 Use of 1-deoxy-D-xylulose-5-phosphate synthase DNA to produce plants with increased tocopherol, vitamin K, chlorophyll and/or carotenoid content
02/10/2000DE19822823A1 Neue Peptidfragmente zur Reinigung von Proteinen New peptide fragments in protein purification
02/10/2000CA2776054A1 Nucleic acids encoding a g-protein coupled receptor involved in sensory transduction
02/10/2000CA2340855A1 Granulocytic ehrlichia genes and uses thereof
02/10/2000CA2339301A1 Hdpbo81 nucleic acids and polypeptides
02/10/2000CA2339121A1 Arrayed biomolecules and their use in sequencing
02/10/2000CA2339016A1 Nucleic acid labeling compounds
02/10/2000CA2338981A1 .alpha.1,3-fucosyltransferase nucleic acid and polypeptide
02/10/2000CA2338643A1 Protein tyrosine phosphatase-1b (ptp-1b) deficient mice and uses thereof
02/10/2000CA2338396A1 Ultrasonic enhancement of drug injection
02/10/2000CA2338247A1 General screening method for ligand-protein interactions
02/10/2000CA2338019A1 Prostate derived ets factor
02/10/2000CA2338001A1 Gastrointestinal bacterial antibody factories
02/10/2000CA2337692A1 Kdel receptor inhibitors
02/10/2000CA2337666A1 Map kinase phosphatase mutant
02/10/2000CA2337496A1 Anti-angiogenesis plasmids and delivery systems, and methods of making and using the same
02/10/2000CA2337493A1 Chlamydia antigens and corresponding dna fragments and uses thereof
02/10/2000CA2337492A1 Delta-related polypeptides
02/10/2000CA2337102A1 Nucleic acids and proteins from group b streptococcus
02/10/2000CA2337092A1 Chlamydia antigens and corresponding dna fragments and uses thereof
02/10/2000CA2337086A1 Eukaryotic cell-based gene interaction cloning
02/10/2000CA2336708A1 Chlamydia antigens and corresponding dna fragments and uses thereof
02/10/2000CA2336706A1 Bending and/or leaning-induced plant promoter
02/10/2000CA2336543A1 Isoforms of human calcium sensing receptor
02/10/2000CA2336539A1 Reversible inhibiting probes
02/10/2000CA2336536A1 Growth differentiation factor-11
02/10/2000CA2336534A1 Chlamydia antigens and corresponding dna fragments and uses thereof
02/10/2000CA2336532A1 Chlamydia antigens and corresponding dna fragments and uses thereof
02/10/2000CA2336530A1 Compositions and methods for the treatment and diagnosis of cardiovascular disease
02/10/2000CA2336486A1 Hla-a2 restricted tumor antigen peptide originated from sart-1
02/10/2000CA2336263A1 Kvlqt1 - a long qt syndrome
02/10/2000CA2336222A1 Serological diagnosis of protostrongylidae infections and identification of unique antigens
02/10/2000CA2335656A1 Human cytoskeletal proteins
02/10/2000CA2335644A1 Phosphorylation effectors
02/10/2000CA2335643A1 C7f2-a novel potassium channel .beta.-subunit
1 ... 3287 3288 3289 3290 3291 3292 3293 3294 3295 3296 3297 3298 3299 3300 3301 3302 3303 3304 3305 3306 3307 ... 4023